Prolactin-blocking drugs may play a role in reversing or preventing post-partum cardiomyopathy (PPCM), according to US research. Studies in mice showed that those that lacked the gene STAT3, specifically in heart muscle cells, consistently developed PPCM. The researchers then found a similar imbalance in humans. However, prolactin-blocking drugs were found to overcome the heart damage caused by a lack of the gene STAT3. Women with PPCM who were given prolactin-blocking drugs showed an increased heart function and all survived the four-month observation period (Cell Online 2007).
- GP - South Milton Keynes Parkside Medical Centre Milton Keynes, Buckinghamshire
- Salaried GP The Robert Darbishire Practice Greater Manchester
- GUARANTEED GP LOCUM WORK ON YOUR DOORSTEP The GP and Nurse Practitioner Agency Nationwide
- OOH GP LOCUM WORK IN YORKSHIRE, MIDLANDS, LONDON, WILTSHIRE, PLYMOUTH, EXETER & SOMERSET The GP and Nurse Practitioner Agency Nationwide
- Locum GP - Surrey & Hampshire - OOH's Shifts DRN Group Surrey, Camberley, Farnborough, Basingstoke, Winchester, Southampton, Portsmouth, Andover